Hiten Patel

@CanesDavid @DrSpratticus @uroegg @ChapinMD @urotoday @UroOnc @Uroweb @wandering_gu @BogdanaSchmidt @DrMLChua @HimanshuNagarMD @AmarUKishan @piet_ost @alison_tree @declangmurphy Adjusting for PIRADS, DRE ended up with the opposite association with csPCa (PMID 35733400, Table 2) than negative or unknown status in PLUM. Excluded from final model. bjui-journals.onlinelibrary.wiley.com/doi/10.1111/bj… Some benefit to DRE in other studies. pubmed.ncbi.nlm.nih.gov/35475129/

@CanesDavid @DrSpratticus @uroegg @ChapinMD @urotoday @UroOnc @Uroweb @wandering_gu @BogdanaSchmidt @DrMLChua @HimanshuNagarMD @AmarUKishan @piet_ost @alison_tree @declangmurphy That's actually better than I expected for DRE, interesting. We compared MRI to TRUS but should have tried to include DRE (TRUS underestimates, PSAD not useful for glands over 80cc). pubmed.ncbi.nlm.nih.gov/36152871/

#EAU26 DRE not recommended for asymptomatic men. What are people’s thoughts on need for routine DRE in era of MRI? @ChapinMD @urotoday @UroOnc @Uroweb @wandering_gu @BogdanaSchmidt @CanesDavid @DrMLChua @HimanshuNagarMD @AmarUKishan @piet_ost @alison_tree @declangmurphy

Analysis with Mitch Huang @NM_Urology @NUFeinbergMed showing uptake of prostate MRI before initial biopsy across the VHA.

Purple = prostate peripheral zone, Green = prostate transition zone, White = seminal vehicles, Brown = PANIC, Yellow = bladder, Orange = Tumor and cytokines

PANIC: PSMA-Ab sensor and destroy Nanoparticle delivery system ligand-based EV-coated Integrated Combo therapy. PCF YI retreat speed networking table 15 #PCFRetreat25 @PCF_Science @SamWashUro @JiaJessieL65499 @UCSFUrology @NM_Urology

ARE WE WITNESSING THE BEST INDIVIDUAL PERFORMANCE EVER IN THE POSTSEASON ⁉️ 🧊 3 HR 🧊 6 scoreless IP 🧊 10 Ks SHOHEI OHTANI IS REALLY HIM 🐐

The hardest lessons after training aren’t always in the OR or clinic. 🙏 I wrote this essay for anyone navigating their first year as an attending. “Unseen Scars” in @JAMA_current 🔗jamanetwork.com/journals/jama/…

The @NorthwesternMed Urology Department is celebrating 125 years of excellence! As we celebrate this historic anniversary, watch as we honor pioneers in the field and reflect on just some of the achievements that exemplify our dedication to better urology. #NMBetter

📰New in @UrolOncol! 💡Highlights: 1⃣Presence of EPE on MRI predicted prostatectomy outcomes 2⃣Combined biopsy showed the highest rate of grade concordance with prostatectomy 3⃣Our model for adverse surgical pat did not outperform existing nomograms 🔗bit.ly/4kGCuoS

Presented at #ASCO25: A 3-year structured exercise program after adjuvant chemotherapy for colon cancer improved disease-free and overall survival, physical functioning, and fitness, as compared with health education alone. Full CHALLENGE phase 3 trial results: nej.md/4mh5RPL @ASCO

So good to see so many friends/colleagues at #AUA25 LV. Now back to reality! @AmerUrological @NM_Urology

Strong Monday showing with Northwestern trainee presentations and the gold medal for the residency abstract Olympics at #AUA25 @AmerUrological @NM_Urology

Congratulations to our hardworking residents for winning 🥇at the National residents abstract Olympics!! @HitenDPatel @evan_panken @Jamie_A_Michael @c_arruzafrau @NM_Urology @NellieB_Uro @EdwardSchaeffer

MP04 session with medical student Jae Jang doing phenomenal job presenting on implications and risks of visible vs invisible GG1 PCa to an engaged audience @AmerUrological @NM_Urology #AUA25

IP04 HSR session with resident Joe Nicolas presenting on a geospatial analysis at Jesse Brown VA @ChicagoVAMC and changes after MISSION Act on utilization of PCa biopsy with purchased care. Old school poster format. @DeptVetAffairs @AmerUrological @NM_Urology #AUA25

MP01 session with resident Jamie Michael doing an excellent job presenting on risk of csPCa after a negative prostate bx in Veterans. Modern poster format. @DeptVetAffairs @AmerUrological @NM_Urology #AUA25

🚨PUBLICATION ALERT🚨 MRI at diagnostic versus confirmatory biopsy during MRI-based active surveillance of prostate cancer Authors included: @HitenDPatel, MD Article Link: pubmed.ncbi.nlm.nih.gov/38890040/

🚨PUBLICATION ALERT🚨 Utility of 18F-DCFPyL PET for local staging for high or very high-risk prostate cancer for patients undergoing radical prostatectomy Authors included: @EricLiUro, MD, @EdwardSchaeffer, MD, PhD, @HitenDPatel, MD, MPH, @ashleyrossmdphd, MD, PhD Article Link: bit.ly/410kzkC

The 2024 Year in Review for Northwestern Medicine Urology is now available online. We proudly highlight significant research discoveries and clinical advances that have the potential to reshape the landscape of urology. This year has been marked by the development of therapies to treat urologic cancers, and breakthrough innovations in biopsy techniques that reduce patient risks. Celebrate these transformative insights and achievements from the past year below. breakthroughsforphysicians.nm.org/urology-news-y…

The Northwestern Medicine Department of Urology is delighted to announce the newest additions to the team! 🎉 Austin Fan, UC San Diego School of Medicine Faraz Longi, Northwestern University Feinberg School of Medicine Devin Boehm, Northwestern University Feinberg School of Medicine Vinaik Sundaresan, Yale School of Medicine @UrologyMatch @AmerUrological @Uro_Res @UroResidency #uromatch2025 #Match2025